|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang ZY: Hepatocellular carcinoma surgery
- review of the past and prospects for the 21st century. J Surg
Oncol. 91:95–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corsini LR, Bronte G, Terrasi M, Amodeo V,
Fanale D, Fiorentino E, Cicero G, Bazan V and Russo A: The role of
microRNAs in cancer: Diagnostic and prognostic biomarkers and
targets of therapies. Expert Opin Ther Targets. 16(Suppl 2):
S103–S109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang RM, Yang H, Fang F, Xu JF and Yang
LY: MicroRNA-331-3p promotes proliferation and metastasis of
hepatocellular carcinoma by targeting PH domain and leucine-rich
repeat protein phosphatase. Hepatology. 60:1251–1263. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tu K, Liu Z, Yao B, Han S and Yang W:
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Int J Oncol. 48:965–974.
2016.
|
|
9
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L,
Zhou JM, Wang LR, Zhang KZ, Zhang QB, Ao JY, et al: MicroRNA-26a
inhibits angiogenesis by down-regulating VEGFA through the
PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma. PLoS One.
8:e779572013. View Article : Google Scholar
|
|
11
|
Sun S, Sun P, Wang C and Sun T:
Downregulation of microRNA-155 accelerates cell growth and invasion
by targeting c-myc in human gastric carcinoma cells. Oncol Rep.
32:951–956. 2014.PubMed/NCBI
|
|
12
|
Li T, Yang J, Lv X, Liu K, Gao C, Xing Y
and Xi T: miR-155 regulates the proliferation and cell cycle of
colorectal carcinoma cells by targeting E2F2. Biotechnol Lett.
36:1743–1752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Zhou J, Zhang Y, Wang Y, Cheng L,
Bai Y and Ma H: The value of microRNA-155 as a prognostic factor
for survival in non-small cell lung cancer: A meta-analysis. PLoS
One. 10:e01368892015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Zhang Y, Liu X, Fang A, Wang J,
Yang Y, Wang L, Du L and Wang C: Direct quantitative detection for
cell-free miR-155 in urine: A potential role in diagnosis and
prognosis for non-muscle invasive bladder cancer. Oncotarget.
7:3255–3266. 2016.
|
|
16
|
Slezak-Prochazka I, Kluiver J, de Jong D,
Smigielska-Czepiel K, Kortman G, Winkle M, Rutgers B, Koerts J,
Visser L, Diepstra A, et al: Inhibition of the miR-155 target NIAM
phenocopies the growth promoting effect of miR-155 in B-cell
lymphoma. Oncotarget. 7:2391–2400. 2016.
|
|
17
|
Baba O, Hasegawa S, Nagai H, Uchida F,
Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T and Bukawa H:
MicroRNA-155-5p is associated with oral squamous cell carcinoma
metastasis and poor prognosis. J Oral Pathol Med. Aug 26–2015.(Epub
ahead of print). PubMed/NCBI
|
|
18
|
Han S, Yang S, Cai Z, Pan D, Li Z, Huang
Z, Zhang P, Zhu H, Lei L and Wang W: Anti-Warburg effect of
rosmarinic acid via miR-155 in gastric cancer cells. Drug Des Devel
Ther. 9:2695–2703. 2015.PubMed/NCBI
|
|
19
|
Shen R, Wang Y, Wang CX, Yin M, Liu HL,
Chen JP, Han JQ and Wang WB: MiRNA-155 mediates TAM resistance by
modulating SOCS6-STAT3 signalling pathway in breast cancer. Am J
Transl Res. 7:2115–2126. 2015.PubMed/NCBI
|
|
20
|
Hou YQ, Yao Y, Bao YL, Song ZB, Yang C,
Gao XL, Zhang WJ, Sun LG, Yu CL, Huang YX, et al: Juglanthraquinone
C induces intracellular ROS increase and apoptosis by activating
the Akt/Foxo signal pathway in HCC cells. Oxid Med Cell Longev.
2016:49416232016. View Article : Google Scholar
|
|
21
|
Ewald F, Nörz D, Grottke A, Bach J,
Herzberger C, Hofmann BT, Nashan B and Jücker M: Vertical targeting
of AKT and mTOR as well as dual targeting of AKT and MEK signaling
is synergistic in hepatocellular carcinoma. J Cancer. 6:1195–1205.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Liao W, Yuan Q, Ou Y and Huang J:
TTK activates Akt and promotes proliferation and migration of
hepatocellular carcinoma cells. Oncotarget. 6:34309–34320.
2015.PubMed/NCBI
|
|
23
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar
|
|
24
|
Nakagawa R, Leyland R, Meyer-Hermann M, Lu
D, Turner M, Arbore G, Phan TG, Brink R and Vigorito E:
MicroRNA-155 controls affinity-based selection by protecting
c-MYC+ B cells from apoptosis. J Clin Invest.
126:377–388. 2016. View
Article : Google Scholar
|
|
25
|
Lerner C, Wemmert S, Bochen F, Kulas P,
Linxweiler M, Hasenfus A, Heinzelmann J, Leidinger P, Backes C,
Meese E, et al: Characterization of miR-146a and miR-155 in blood,
tissue and cell lines of head and neck squamous cell carcinoma
patients and their impact on cell proliferation and migration. J
Cancer Res Clin Oncol. Nov 30–2015.(Epub ahead of print).
PubMed/NCBI
|
|
26
|
Hou L, Chen J, Zheng Y and Wu C: Critical
role of miR-155/FoxO1/ROS axis in the regulation of non-small cell
lung carcinomas. Tumour Biol. Nov 9–2015.(Epub ahead of print).
|
|
27
|
You J, Yang H, Lai Y, Simon L, Au J and
Burkart AL: ARID2, p110α, p53, and β-catenin protein expression in
hepatocellular carcinoma and clinicopathologic implications. Hum
Pathol. 46:1068–1077. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raab JR, Resnick S and Magnuson T:
Genome-wide transcriptional regulation mediated by biochemically
distinct SWI/SNF complexes. PLoS Genet. 11:e10057482015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu P, Wu D, You Y, Sun J, Lu L, Tan J and
Bie P: miR-208-3p promotes hepatocellular carcinoma cell
proliferation and invasion through regulating ARID2 expression. Exp
Cell Res. 336:232–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
